District of Columbia

PharmaPatents

The author keeps an eagle eye on developments in the chemical, biotech, and pharmaceutical industry, and discusses recent cases and USPTO decisions that may affect how patents are granted and protected.

The BLT: The Blog of Legal Times

"Law and lobbying in the nation's capital." While the BLT's law firm news for the most part stays inside the Beltway, its concise and timely original reporting on all three branches of the federal government gives it national appeal.